News Sentiment

GMAB sentiment intelligence

Genmab A/S news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 54 Balanced news tone 23 relevant articles
Exchange VIE Austria
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 250.30 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

83/100 classification confidence.

Company focus 23

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+0.1% over one week, +16.1% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Analysts Are Bullish on Top Healthcare Stocks: Chemomab Therapeutics (CMMB), Genmab (GMAB)

Market Reaction

Balanced read

54/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 83/100 classification
One-week reaction 0.1% Price digesting
Trend fit Trend inactive 16.1% over four weeks
Fair value 1.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 13
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 23
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 10
marketscreener.com 6
Stock Titan 4
The Globe and Mail 1
DirectorsTalk Interviews 1
Quiver Quantitative 1

Event Lens

What the news is about

Classified themes
Market update 15
Earnings 4
Analyst action 4

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-23 of 23